BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

3:48 PM
 | 
May 25, 2018
 |  BC Extra  |  Company News

Management tracks: ISA, ImCheck, ArQule

Immunotherapy company ISA Pharmaceuticals B.V. (Leiden, the Netherlands) promoted CBO Gerben Moolhuizen to CEO, effective June 1. He succeeds CEO Ronald Loggers. Also in May, ISA hired Leon Hooftman as CMO. Hooftman was CMO at Allecra Therapeutics GmbH (Lörrach, Germany).

Immunomodulatory antibody company ImCheck Therapeutics S.A.S. (Marseille, France) appointed Debasish Roychowdhury as chairman. He is CMO at Partner Therapeutics Inc. (Boston, Mass.).

Precision medicine company ArQule Inc. (NASDAQ:ARQL) hired Marc Shegerin as SVP of corporate strategy, communication and...

Read the full 370 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >